Safety and Efficacy of Saroglitazar in Nonalcoholic Fatty Liver Patients With Diabetic Dyslipidemia—A Prospective, Interventional, Pilot Study
Nanditha Rajesh, L. Drishya, Murali Mohan Raju Ambati, Athi L. Narayanan, Maria Alex, Kiran Kumar Rathinam, Justin Jacob Abraham, T Vijayakumar
Topics & Concepts
MedicineDyslipidemiaInternal medicineNonalcoholic fatty liver diseaseDiabetes mellitusGastroenterologyLiver diseaseAdverse effectProspective cohort studyFatty liverEndocrinologyObesityDiseaseLiver Disease Diagnosis and TreatmentDiabetes, Cardiovascular Risks, and LipoproteinsPeroxisome Proliferator-Activated Receptors